XML 37 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Schedule of Segment Information) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 27 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Imprelis [Member]
Sep. 30, 2012
Imprelis [Member]
Sep. 30, 2013
Imprelis [Member]
Sep. 30, 2012
Imprelis [Member]
Sep. 30, 2013
Imprelis [Member]
Sep. 30, 2013
Agriculture [Member]
Sep. 30, 2012
Agriculture [Member]
Sep. 30, 2013
Agriculture [Member]
Sep. 30, 2012
Agriculture [Member]
Dec. 31, 2012
Agriculture [Member]
Sep. 30, 2013
Agriculture [Member]
Imprelis [Member]
Sep. 30, 2012
Agriculture [Member]
Imprelis [Member]
Sep. 30, 2013
Agriculture [Member]
Imprelis [Member]
Sep. 30, 2012
Agriculture [Member]
Imprelis [Member]
Sep. 30, 2013
Electronics and Communications [Member]
Sep. 30, 2012
Electronics and Communications [Member]
Sep. 30, 2013
Electronics and Communications [Member]
Sep. 30, 2012
Electronics and Communications [Member]
Sep. 30, 2013
Industrial Biosciences [Member]
Sep. 30, 2012
Industrial Biosciences [Member]
Sep. 30, 2013
Industrial Biosciences [Member]
Sep. 30, 2012
Industrial Biosciences [Member]
Sep. 30, 2013
Nutrition and Health [Member]
Sep. 30, 2012
Nutrition and Health [Member]
Sep. 30, 2013
Nutrition and Health [Member]
Sep. 30, 2012
Nutrition and Health [Member]
Sep. 30, 2013
Performance Chemicals [Member]
Sep. 30, 2012
Performance Chemicals [Member]
Sep. 30, 2013
Performance Chemicals [Member]
Sep. 30, 2012
Performance Chemicals [Member]
Sep. 30, 2013
Performance Chemicals [Member]
Titanium Dioxide Antitrust Litigation [Member]
Sep. 30, 2013
Performance Chemicals [Member]
Titanium Dioxide Antitrust Litigation [Member]
Sep. 30, 2013
Performance Materials [Member]
Sep. 30, 2012
Performance Materials [Member]
Sep. 30, 2013
Performance Materials [Member]
Sep. 30, 2012
Performance Materials [Member]
Sep. 30, 2013
Safety and Protection [Member]
Sep. 30, 2012
Safety and Protection [Member]
Sep. 30, 2013
Safety and Protection [Member]
Sep. 30, 2012
Safety and Protection [Member]
Sep. 30, 2013
Pharmaceuticals [Member]
Sep. 30, 2012
Pharmaceuticals [Member]
Sep. 30, 2013
Pharmaceuticals [Member]
Sep. 30, 2012
Pharmaceuticals [Member]
Sep. 30, 2013
Other [Member]
Sep. 30, 2012
Other [Member]
Sep. 30, 2013
Other [Member]
Sep. 30, 2012
Other [Member]
Sep. 30, 2012
INVISTA [Member]
Other [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Agriculture [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Agriculture [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Electronics and Communications [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Electronics and Communications [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Industrial Biosciences [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Industrial Biosciences [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Nutrition and Health [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Nutrition and Health [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Performance Chemicals [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Performance Chemicals [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Performance Materials [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Performance Materials [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Safety and Protection [Member]
Sep. 30, 2012
Restructuring Program 2012 [Member]
Safety and Protection [Member]
Segment sales $ 7,813 $ 7,480 $ 28,232 $ 27,797           $ 1,633 $ 1,423 $ 9,933 [1] $ 8,891           $ 638 $ 607 $ 1,907 $ 2,079 $ 305 $ 292 $ 898 $ 880 $ 868 $ 876 $ 2,601 $ 2,569 $ 1,720 $ 1,732 $ 5,087 $ 5,600     $ 1,663 $ 1,614 $ 4,892 $ 4,913 $ 985 $ 934 $ 2,909 $ 2,861 $ 0 $ 0 $ 0 $ 0 $ 1 $ 2 $ 5 $ 4                                  
Less: Transfers 78 90 245 310           3 0 10 [1] 4           3 4 12 13 3 3 10 8 0 0 0 0 46 56 153 202     22 24 57 74 1 3 3 9 0 0 0 0 0 0 0 0                                  
Net sales 7,735 7,390 27,987 27,487           1,630 1,423 9,923 [1] 8,887           635 603 1,895 2,066 302 289 888 872 868 876 2,601 2,569 1,674 1,676 4,934 5,398     1,641 1,590 4,835 4,839 984 931 2,906 2,852 0 0 0 0 1 2 5 4                                  
PTOI 741 461 4,759 4,845           (102) [2] (198) [2],[3] 2,240 [1],[2] 1,772 [2],[3]           97 (99) [3],[4] 241 181 [3],[4],[5] 45 37 [3] 129 118 [3] 81 64 [3] 218 248 [3] 182 [6] 410 [3] 697 [6] 1,575 [3]     374 230 [3],[4] 1,002 851 [3],[4] 171 92 [3] 481 432 [3] 5 10 27 53 (112) (85) (276) (385) [7]                                  
Segment net assets                   9,692   9,692   4,756                                                                                                              
Increase in net assets                       4,936                                                                                                                  
Loss Contingency         (65) (125) (180) (440) (930)           (65) (125) (180) (440)                                 (72) (72)                                                                  
Insurance recoveries         25   25               25   25                                                                                                        
Gain on sale of equity method investment                                           122                                                                                              
Charge related to litigation settlement                                                                                                         (137)                                
Restructuring charge                                                                                                           (93) (93) (3) (3) (7) (7) (3) (3) (13) (13) (3) (3) (9) (9) (55) (55)
Asset Impairment Charges   $ (242)   $ (242)                               $ (150)   $ (150)                               $ (92)   $ (92)                                                          
[1] As of September 30, 2013, Agriculture net assets were $9,692, an increase of $4,936 from $4,756 at December 31, 2012. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
[2] Included charges of $(65) and $(180), offset by $25 of insurance recoveries, during the three and nine months ended September 30, 2013, respectively, and charges of $(125) and $(440) during the three and nine months ended September 30, 2012, respectively, recorded in other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 9 for additional information.
[3] Included a $(93) restructuring charge impacting the following segments: Agriculture - $(3), Electronics & Communications - $(7), Industrial Biosciences - $(3), Nutrition & Health - $(13), Performance Chemicals - $(3), Performance Materials - $(9), and Safety & Protection - $(55).
[4] Included a $(242) impairment charge recorded in employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150) and Performance Materials - $(92). See Note 3 for additional information.
[5] Included a $122 gain recorded in other income, net related to the sale of the company's interest in an equity method investment.
[6] Included a $(72) charge related to the titanium dioxide antitrust litigation. See Note 9 for additional information.
[7] Included a $(137) charge recorded in other operating charges related to the company's settlement of litigation with INVISTA.